Q3 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript
Greetings. Welcome to Avadel Third Quarter 2019 Earnings Call. (Operators Instructions) Please note, this conference is being recorded.
I will now turn the conference over to your host, Mr. Michael Kanan, Chief Financial Officer. Please go ahead.
Good morning and thank you for joining us on our conference call. This morning, we issued our third quarter 2019 financial results news release. The release can be accessed on our website at avadel.com.
As a reminder, before we begin, the following presentation includes a number of matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include that products in the development stage may not achieve scientific objectives or milestones or meet stringent regulatory requirements, uncertainties regarding market acceptance of products and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |